Scott Requadt

Insider Reports History

Entity
Individual
Location
101 Main Street, Suite 1210, Cambridge, MA
Signature
/s/ Scott Requadt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott Requadt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Talaris Therapeutics, Inc. Former Chief Executive Officer Common Stock 578K $9.83M $16.99 Jul 3, 2023 Direct
Talaris Therapeutics, Inc. Former Chief Executive Officer Common Stock 450K $7.64M $16.99 Jul 3, 2023 Indirect
ESSA Pharma Inc. Director Common Shares 30K $300K $10.01 Nov 6, 2023 Direct
Talaris Therapeutics, Inc. Former Chief Executive Officer Stock Appreciation Right 320K Feb 1, 2023 Direct
Talaris Therapeutics, Inc. Former Chief Executive Officer Stock Option (Right to Buy) 320K Feb 1, 2023 Direct
ESSA Pharma Inc. Director Options 50K Mar 25, 2024 Direct

Insider Reports Filed by Scott Requadt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EPIX ESSA Pharma Inc. Mar 25, 2024 1 $0 4 Mar 28, 2024 Director
EPIX ESSA Pharma Inc. Oct 30, 2023 2 $0 4 Jan 16, 2024 Director
TALS Talaris Therapeutics, Inc. Jul 3, 2023 1 -$36.3K 4 Jul 6, 2023 Former Chief Executive Officer
TALS Talaris Therapeutics, Inc. Feb 1, 2023 3 $3.47 4 Feb 3, 2023 Chief Executive Officer, Director
TALS Talaris Therapeutics, Inc. Sep 10, 2022 1 $0 4 Sep 13, 2022 Chief Executive Officer, Director
TALS Talaris Therapeutics, Inc. Jul 29, 2022 1 $167K 4 Aug 2, 2022 Chief Executive Officer, Director
TALS Talaris Therapeutics, Inc. Jul 26, 2022 2 $36.6K 4 Jul 28, 2022 Chief Executive Officer, Director
TALS Talaris Therapeutics, Inc. Jul 22, 2022 1 $35.4K 4 Jul 26, 2022 Chief Executive Officer, Director
EPIX ESSA Pharma Inc. Jun 29, 2022 1 $0 4 Nov 1, 2022 Director
TALS Talaris Therapeutics, Inc. Feb 1, 2022 2 $19.1K 4 Feb 2, 2022 Chief Executive Officer, Director